Undisclosed fully-armed CAR T-cell product
/ Lyell Immunopharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
November 12, 2025
Lyell is advancing next-generation fully-armed CAR T-cell product candidates…
(GlobeNewswire)
- "The first IND for a fully-armed CAR T-cell product candidate with an undisclosed target for solid tumors is expected in 2026."
IND • Solid Tumor
August 12, 2025
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
(GlobeNewswire)
- "The first IND for a fully-armed CAR T-cell product candidate with an undisclosed target for solid tumors is expected in 2026."
IND • Solid Tumor
March 11, 2025
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024
(GlobeNewswire)
- "Preclinical Pipeline:...The first IND for a fully-armed CAR T-cell product candidate with an undisclosed target for solid tumors is expected in 2026."
IND • Solid Tumor
1 to 3
Of
3
Go to page
1